drugset / Trial / NCT00003465

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

NCT00003465 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients with anaplastic oligodendroglioma.

Timeline

Start
1998-03
Primary completion
—
Completion
2001-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral